Healthcare ❯ Vaccines

COVID-19 Vaccines

Insurance Coverage Effectiveness FDA Regulations mRNA Technology Comirnaty Updated Vaccines FDA Approval Comparative Analysis Approval Process Moderna's COVID-19 Vaccine Vaccine Policy Covaxin Oxford-AstraZeneca Vaccine mRNA Vaccines Affordable Care Act Access Restrictions RSV Vaccines Spikevax Efficacy Vaccine Efficacy Moderna and Pfizer Vaccine Controversies

Moderna Reaches Up to $2.25 Billion LNP Patent Settlement, Pays $950 Million Upfront

The settlement grants Moderna a global license with no royalties, leaving a narrow government‑liability appeal as the only remaining issue.

Pfizer Sets 2026 Targets Below Wall Street as COVID Sales Fade, Patent Pressure Builds

Greene Urges DOJ to Drop Charges Against Surgeon on Trial for COVID-19 Vaccine Fraud